VolitionRx reports its finger-prick lateral flow prototype for sepsis shows strong correlation with its automated Nu.Q NETs assay, supporting point-of-care nucleosome testing for critically ill patients.
The Enhancing CLIA Act, introduced in Congress as H.R. 8890, proposes modernizing the CLIA framework for laboratory-developed tests and reaffirms CMS—not FDA—oversight of LDTs, signaling potential regulatory changes for labs.
ADLM 2026 drew nearly 17,000 professionals to Anaheim, where experts discussed advances in space diagnostics, mass spectrometry, and chronic disease management, and Kompass Diagnostics won the Disruptive Technology Award for its IDA platform.
ProtaGene’s Heidelberg, Germany, lab has received CAP and CLIA accreditation, authorizing integration site analysis on human samples for lentivirus-based cell and gene therapy under U.S. federal regulations.
Magnolia Diagnostics and its owners will pay $19.2 million to resolve DOJ claims of billing Medicare for unnecessary respiratory tests with COVID-19 screening; investors will pay an additional $4.8 million for related allegations.
Lot-to-lot reagent inconsistencies can have significant effects on patient test results.
Roche Diagnostics North America and Ivy Tech Community College have launched a multi-phase initiative, including scholarships and an awareness campaign, to address clinical lab workforce shortages in Indiana.
Position your laboratory for the future of hemostasis testing This sponsored white paper explores how advances in automation, workflow optimization, and intelligent coagulation analysis are helping laboratories improve...